Annual report pursuant to Section 13 and 15(d)

Consolidated Condensed Balance Sheets (Parenthetical)

v3.23.1
Consolidated Condensed Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Sep. 08, 2021
Current assets:      
Accounts Receivable, Allowance $ 0 $ 39  
Stockholders' equity:      
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001  
Common stock, shares authorized (in shares) 300,000,000 300,000,000  
Common stock, shares issued (in shares) 121,938,000 117,160,000  
Common stock shares outstanding (in shares) 119,508,000 114,452,000 31,625,000